Cornercap Investment Counsel Inc Century Therapeutics, Inc. Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 51,520 shares of IPSC stock, worth $116,950. This represents 0.03% of its overall portfolio holdings.
Number of Shares
51,520
Previous 51,520
-0.0%
Holding current value
$116,950
Previous $171,000
25.73%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding IPSC
# of Institutions
67Shares Held
19.7MCall Options Held
10.6KPut Options Held
300-
Vr Adviser, LLC New York, NY3.41MShares$7.73 Million1.22% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$7.28 Million1.08% of portfolio
-
Boxer Capital, LLC San Diego, CA1.75MShares$3.97 Million0.38% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$3.4 Million0.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.31MShares$2.97 Million1.32% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $134M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...